This is the authors' abstract. We don't add key points for this paper.
The therapeutic index of antimetabolites such as purine analogues is in large part determined by the extent to which it is selectively accumulated by the target cell. In the current study we have compared the transport of purine nucleobase analogues by the H2 transporter of bloodstream form Trypanosoma brucei bruceiand the equilibrative nucleobase transporter of human erythrocytes. The H2 transporter forms hydrogen bonds with hypoxanthine at positions N3, N7, N(1)H, and N(9)H of the purine ring, with apparent ΔG 0 of 7.7–12.6 kJ/mol. The transporter also appears to H-bond with the amine group of adenine. The human transporter forms hydrogen bonds that form to (6De Koning H.P. Jarvis S.M. Biochem. Cell Biol. 1998; 76: 853-858Crossref PubMed Google Scholar)NH2 and N1 of adenine. An H-bond is also formed with N3 and the 6-keto and amine groups of guanine but not with the protonated N1, thus explaining the low affinity for hypoxanthine. N7 and N9 do not directly interact with the human transporter in the form of H-bonds, and it is proposed that π-π stacking interactions contribute significantly to permeant binding. The potential for selective uptake of antimetabolites by the parasite transporter was demonstrated. The therapeutic index of antimetabolites such as purine analogues is in large part determined by the extent to which it is selectively accumulated by the target cell. In the current study we have compared the transport of purine nucleobase analogues by the H2 transporter of bloodstream form Trypanosoma brucei bruceiand the equilibrative nucleobase transporter of human erythrocytes. The H2 transporter forms hydrogen bonds with hypoxanthine at positions N3, N7, N(1)H, and N(9)H of the purine ring, with apparent ΔG 0 of 7.7–12.6 kJ/mol. The transporter also appears to H-bond with the amine group of adenine. The human transporter forms hydrogen bonds that form to (6De Koning H.P. Jarvis S.M. Biochem. Cell Biol. 1998; 76: 853-858Crossref PubMed Google Scholar)NH2 and N1 of adenine. An H-bond is also formed with N3 and the 6-keto and amine groups of guanine but not with the protonated N1, thus explaining the low affinity for hypoxanthine. N7 and N9 do not directly interact with the human transporter in the form of H-bonds, and it is proposed that π-π stacking interactions contribute significantly to permeant binding. The potential for selective uptake of antimetabolites by the parasite transporter was demonstrated. human facilitative nucleobase transporter 1 adenine-9-β-d-arabinoside Purine and pyrimidine antimetabolites are widely used to combat a variety of infectious diseases and other pathologies. However, many therapies suffer from a lack of selectivity, leading to severe side effects. The selectivity and efficacy of purine antimetabolites is achieved at two levels: the cell-surface transporters that mediate access to the cell, and the enzymes of the purine metabolic pathways that convert the pro-drug to the cytotoxic metabolite, usually a nucleotide analogue. This report elucidates the mechanisms of selectivity at the transporter level. We have chosen Trypanosoma brucei, the etiological agent of sleeping sickness, as a model organism, because it lives freely in the host bloodstream rather than within a host cell. Therefore, the accumulation of most nucleobase and nucleoside drugs depends exclusively on the transporters expressed by the parasite itself. In addition, African trypanosomes are entirely dependent on purine salvage because they lack the capacity for de novosynthesis (1Hammond D.J. Gutteridge W.E. Mol. Biochem. Parasitol. 1984; 13: 243-261Crossref PubMed Scopus (221) Google Scholar), and they consequently express several proton symporters that actively accumulate nucleosides (2Carter N.S. Fairlamb A.H. Nature. 1993; 361: 173-176Crossref PubMed Scopus (310) Google Scholar, 3De Koning H.P. Watson C.J. Jarvis S.M. J. Biol. Chem. 1998; 273: 9486-9494Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar) and nucleobases (4De Koning H.P. Jarvis S.M. Mol. Biochem. Parasitol. 1997; 89: 245-258Crossref PubMed Scopus (64) Google Scholar, 5De Koning H.P. Jarvis S.M. Eur. J. Biochem. 1997; 247: 1102-1110Crossref PubMed Scopus (50) Google Scholar, 6De Koning H.P. Jarvis S.M. Biochem. Cell Biol. 1998; 76: 853-858Crossref PubMed Google Scholar). For trypanosomes, nucleobases may make more efficient drugs than their corresponding nucleosides, because purine ribonucleosides are rapidly hydrolyzed in bloodstream form T. brucei, limiting their incorporation into the nucleotide pool (7Fish W.R. Looker D.L. Marr J.J. Berens R.L. Biochim. Biophys. Acta. 1982; 719: 223-231Crossref PubMed Scopus (42) Google Scholar). In contrast, nucleobases are efficiently assimilated by one-step reactions of phosphoribosyltransferases for adenine, hypoxanthine-guanine, and xanthine (8Berens R.L. Krug E.C. Marr J.J. Marr J.J. Müller M. Biochemistry and Molecular Biology of Parasites. Academic Press Ltd., New York1995: 89-117Crossref Google Scholar). The current study therefore focuses on the mainT. brucei brucei and human nucleobase transporters. This approach will allow the identification of groups that determine high affinity uptake by either the trypanosome or the cells of its mammalian host. The escalating epidemic of African trypanosomiasis (9Barrett M.P. Lancet. 1999; 353: 1113-1114Abstract Full Text Full Text PDF PubMed Scopus (121) Google Scholar) and the onset of drug resistance (10Kaminsky R. Mäser P. Curr. Opin. Anti-infect. Invest. Drugs. 2000; 2: 76-82Google Scholar) necessitate the development of a new generation of trypanocides, and the purine salvage pathways are potential targets for chemotherapeutic intervention. Purine nucleobase transport in bloodstream T. b. brucei has been previously characterized, and two distinct carriers, H2 and H3, were identified. The H2 displayed a much higher affinity and a broader specificity than H3 (4De Koning H.P. Jarvis S.M. Mol. Biochem. Parasitol. 1997; 89: 245-258Crossref PubMed Scopus (64) Google Scholar). The almost 100-fold difference inK m for these transporters allows the study of the H2 transporter separately at a very low [3H]hypoxanthine concentration. We have now determined the substrate recognition motif for H2 and compared it with that of the human facilitative diffusion nucleobase transporter (hFNT1),1 which is the only nucleobase transporter in erythrocytes (11Griffith D.A. Jarvis S.M. Biochim. Biophys. Acta. 1996; 1286: 153-181Crossref PubMed Scopus (453) Google Scholar, 12De Koning H.P. Diallinas G. Mol. Membr. Biol. 2000; 75: 75-94Google Scholar) but has also been described in various other tissues (13Griffith D.A. Jarvis S.M. J. Biol. Chem. 1993; 268: 20085-20090Abstract Full Text PDF PubMed Google Scholar, 14Shayeghi M. Akerman R. Jarvis S.M. Biochim. Biophys. Acta. 1999; 1416: 109-118Crossref PubMed Scopus (21) Google Scholar, 15Haddock P.S. Cardiovasc. Res. 1995; 30: 130-137Crossref PubMed Scopus (8) Google Scholar, 16Ullman B. Patrick J. McCartan K. Mol. Cell. Biol. 1987; 7: 97-103Crossref PubMed Scopus (19) Google Scholar, 17Gati W.P. Paterson A.R. Tyrrell D.L. Cass C.E. Moravek J. Robins M.J. J. Biol. Chem. 1992; 267: 22272-22276Abstract Full Text PDF PubMed Google Scholar) and been shown to mediate the uptake of several chemotherapeutic purine analogues (17Gati W.P. Paterson A.R. Tyrrell D.L. Cass C.E. Moravek J. Robins M.J. J. Biol. Chem. 1992; 267: 22272-22276Abstract Full Text PDF PubMed Google Scholar, 18Mahony W.B. Domin B.A. Daluge S.M. Miller W.H. Zimmerman T.P. J. Biol. Chem. 1992; 267: 19792-19797Abstract Full Text PDF PubMed Google Scholar, 19Mahony W.B. Domin B.A. McConnell R.T. Zimmerman T.P. J. Biol. Chem. 1988; 263: 9285-9291Abstract Full Text PDF PubMed Google Scholar, 20Mahony W.B. Domin B.A. Zimmerman T.P. Biochem. Pharmacol. 1991; 41: 263-271Crossref PubMed Scopus (39) Google Scholar). This approach to comparing transporters is all the more relevant because molecular approaches are unavailable: no protozoan or metazoan nucleobase transporters have yet been cloned. Substrate recognition motifs have been shown to accurately predict the uptake of chemotherapeutic agents by T. b. brucei. Such models were developed for the T. b. brucei P1 and P2 adenosine transporters (21De Koning H.P. Jarvis S.M. Mol. Pharmacol. 1999; 56: 1162-1170Crossref PubMed Scopus (129) Google Scholar) and showed that the recognition motif of P2, but not of P1, was present in trypanocides as different as diamidines, melaminophenyl arsenicals, and isometamidium (a phenanthridine-amidine hybrid). All these have now been shown to be transported by P2 or at least to bind to the transporter with sub-micromolar affinity (2Carter N.S. Fairlamb A.H. Nature. 1993; 361: 173-176Crossref PubMed Scopus (310) Google Scholar, 22De Koning H.P. Int. J. Parasitol. 2001; 31: 512-522Crossref PubMed Scopus (99) Google Scholar, 23De Koning H.P. Mol. Pharmacol. 2001; 59: 586-592Crossref PubMed Scopus (128) Google Scholar, 24De Koning H.P. Jarvis S.M. Acta Trop. 2001; 80: 245-250Crossref PubMed Scopus (57) Google Scholar, 25Carter N.S. Berger B.J. Fairlamb A.H. J. Biol. Chem. 1995; 270: 28153-28157Abstract Full Text Full Text PDF PubMed Scopus (187) Google Scholar). We now show, on the basis of the H2 and hFNT1 substrate recognition motifs, that selective uptake of subversive nucleobase analogues by trypanosomes is possible and provide a structural rationale for the selection of such compounds. We also show that selective uptake alone is an insufficient requirement for trypanocidal action and that further studies of purine metabolism in trypanosomes will be required for rational design of antimetabolites. [8-3H]Hypoxanthine (1.18 TBq/mmol) was purchased from Amersham Pharmacia Biotech, UK. [2,8-3H]Adenine (1.2 TBq/mmol) was obtained from PerkinElmer Life Sciences. Natural and purine analogues were purchased from and and was from and were by the of of the of was a from of the was by of the of were b. brucei by was by The were from the cells a S.M. Nature. PubMed Scopus Google Scholar), in the and at Cell and were a at the of from human was and cells were in and at a of the was of hypoxanthine in T. b. brucei was determined as previously described Koning H.P. Watson C.J. Jarvis S.M. J. Biol. Chem. 1998; 273: 9486-9494Abstract Full Text Full Text PDF PubMed Scopus (79) Google Scholar, 5De Koning H.P. Jarvis S.M. Eur. J. Biochem. 1997; 247: 1102-1110Crossref PubMed Scopus (50) Google Scholar), with of the trypanosome was with of [3H]hypoxanthine and was by of an of hypoxanthine and an of and The were in and the the was The cells were in and with and the was determined in a of 1 by human erythrocytes was by an for the and were in of and was with of the was to and with of and the was All uptake are to as uptake to be uptake in the of of were used from in in the which not uptake by either erythrocytes or In a not be obtained to of the to as to transport in the of of was achieved at the was an a of are in and for purine and pyrimidine of and T. b. 0 0 from Koning and Jarvis from Koning and Jarvis from Koning and Jarvis from Koning and Jarvis from Koning and Jarvis from not from from no at the from from from from from from from from at a of 1 at a of 1 from Koning and Jarvis from Koning and Jarvis from Koning and Jarvis from Koning and Jarvis from Koning and Jarvis from Koning and Jarvis from Koning and Jarvis for of uptake were from obtained from such as in 1 and as described All are the of to of of is and was only was achieved at the and and a of were This has been because of of from Koning and Jarvis (4De Koning H.P. Jarvis S.M. Mol. Biochem. Parasitol. 1997; 89: 245-258Crossref PubMed Scopus (64) Google from not no at the at a of 1 in a new for of uptake were from obtained from such as in 1 and as described All are the of to of of is and was only was achieved at the and and a of were This has been because of of compounds. of in were determined from the for the various the The W.H. Biochem. Pharmacol. PubMed Scopus Google Scholar) was used to for the 1 in which is the permeant concentration. ΔG was in which is the and is the to be that these are only for The that for H2 and hFNT1 were is with of a bloodstream trypanosomes do express two distinct purine nucleobase the chosen [3H]hypoxanthine allows for uptake by H2 (4De Koning H.P. Jarvis S.M. Mol. Biochem. Parasitol. 1997; 89: 245-258Crossref PubMed Scopus (64) Google Scholar). of T. b. brucei purine transporters by analogues has been shown to be (2Carter N.S. Fairlamb A.H. Nature. 1993; 361: 173-176Crossref PubMed Scopus (310) Google Scholar, 5De Koning H.P. Jarvis S.M. Eur. J. Biochem. 1997; 247: 1102-1110Crossref PubMed Scopus (50) Google Scholar, 23De Koning H.P. Mol. Pharmacol. 2001; 59: 586-592Crossref PubMed Scopus (128) Google Scholar, 24De Koning H.P. Jarvis S.M. Acta Trop. 2001; 80: 245-250Crossref PubMed Scopus (57) Google Scholar), and hypoxanthine and were shown to the transporter in human erythrocytes M. R. G. M. M. P. Biochim. Biophys. Acta. 1991; PubMed Scopus Google Scholar). All the therefore that a model of with the permeant for with the transporter is in bloodstream trypanosomes was the of B. M. R. R. Acta Trop. 1997; PubMed Scopus Google Scholar). of were in by of of at to of 1 1 1 from from K. J. Parasitol. 75: PubMed Scopus Google Scholar). were obtained from with of of trypanocides such as of bloodstream T. b. brucei, was The were at for which of was a further was determined in a PerkinElmer Life Natural and a variety of purine analogues were for their to trypanosome or human nucleobase transport the in the the transporters and the different be and The were determined from and ΔG 0 for the transporter and permeant were to the and for transporters. The of the H2 hypoxanthine transporter have been described hypoxanthine uptake is and at least with a m of and a of (4De Koning H.P. Jarvis S.M. Mol. Biochem. Parasitol. 1997; 89: 245-258Crossref PubMed Scopus (64) Google Scholar). we its substrate recognition and present a model for the interactions purine and transporter The T. b. brucei H2 transporter has for as by the for hypoxanthine than for is an apparent the H2 and the as by the difference of in ΔG 0 and purine This at a hydrogen is with the 6-keto group of not contribute to their high for guanine and are the group be a hydrogen that the of N1, the only other difference hypoxanthine and is for the difference in ΔG 0 1 The in was of the 6-keto group of hypoxanthine 1 which the of N1, and the apparent of a hydrogen in that The of hypoxanthine and is thus by a of from from the of the with The N1 not contribute to to the H2 for purine and and were The affinity for guanine than for hypoxanthine that at may be for to other and an of of from the The was more to the affinity be the of these also the on N3, a hydrogen that N3 in is by the difference guanine and of N3 to a in because to [3H]hypoxanthine uptake the of N3 of the substrate in the The pyrimidine thus to the of for the interactions the hypoxanthine and the a from the of with only of the pyrimidine of hypoxanthine displayed a of compared with hypoxanthine 1 the of which is to but with a of was with The of N7 in most as a hydrogen most directly from the and guanine In addition, the affinity for is significantly compared with its of that a is possible with the that has from to no on [3H]hypoxanthine uptake at to the of N7 in the form of the group not to the for to but an not be obtained to of The of the H2 transporter for nucleobases nucleosides that N(9)H may be in interactions with the transporter or that the with the of the purine The of and was compared with their that N(9)H most as a hydrogen the higher difference in ΔG 0 most nucleobases and their nucleosides it is that contribute to the low affinity for The H2 transporter therefore interactions to bind either or The ΔG of hypoxanthine and on their m are in of the of the interactions and of 1 by human erythrocytes was and with a of This was by in the of 1 permeant and that transport was In all uptake in human erythrocytes was with a with a transport for adenine, as by Koning H.P. Diallinas G. Mol. Membr. Biol. 2000; 75: 75-94Google Scholar, M. R. G. M. M. P. Biochim. Biophys. Acta. 1991; PubMed Scopus Google Scholar). The transport to with an m of and of were obtained a of 1 and an of either or which of by human erythrocytes. of 1 by human erythrocytes was determined in the of to or For transport was expressed as a of the as uptake in the of for transport was expressed as a m of and a of purine and and and All were in and of or The human nucleobase transporter displayed a for with a for hypoxanthine of higher than the m for adenine. This to from interactions with N1 and but not with The of N1 from the purine and of the difference purine and of that the amine group as an H-bond to a in the transporter the and hypoxanthine is only that either the 6-keto group or the proton on N1 to extent to its by The for is than for guanine is therefore most that the group as an for a hydrogen because in the rather than and the group is much of an H-bond than is the The difference of in purine and hypoxanthine that the H-bond with N1 is than the to also that is no from to the of because have significantly its low The for analogues with other at as or that do not the of N1 was not significantly different from the ΔG 0 for purine in of of with and amine at The be from the of guanine and or and the is from the higher affinity for guanine than for hypoxanthine The of xanthine and to uptake at the of their is with the of an H-bond at and an H-bond at The ΔG 0 for these interactions the for adenine, and guanine interactions with the pyrimidine of the to and which is than the However, N7 N9 a in the with because and all have higher affinity than guanine to hypoxanthine the ring, displayed a very low affinity and a ΔG 0 of higher than hypoxanthine the and in the ring, displayed a affinity than on hFNT1 transport at as high as and has consequently a compared with The are all with to interactions of the purine ring, and in the with the of in the hFNT1 rather than to N7 or N9 of the nucleobases in on trypanosome at to and The most analogues were and adenine-9-β-d-arabinoside In report we have purine nucleobase transport in human erythrocytes and T. brucei that freely in the mammalian bloodstream and therefore the with their transporters for the For the T. b. brucei H2 we on previously (4De Koning H.P. Jarvis S.M. Mol. Biochem. Parasitol. 1997; 89: 245-258Crossref PubMed Scopus (64) Google Scholar). The and substrate specificity for the facilitative nucleobase transporter in human erythrocytes have also been previously Koning H.P. Diallinas G. Mol. Membr. Biol. 2000; 75: 75-94Google Scholar, B.A. W.B. Zimmerman T.P. J. Biol. Chem. 1988; 263: Full Text PDF PubMed Google Scholar, Biochim. Biophys. Acta. 1988; PubMed Scopus Google Scholar), and the current the developed by Domin B.A. W.B. Zimmerman T.P. J. Biol. Chem. 1988; 263: Full Text PDF PubMed Google Scholar), are in with m for adenine, and the of are very to previously B.A. W.B. Zimmerman T.P. J. Biol. Chem. 1988; 263: Full Text PDF PubMed Google Scholar), and the for of is to the m of M. M. R. Biochem. Pharmacol. 1993; PubMed Scopus Google Scholar). We have now these studies to a large of potential with the of the interactions permeant and transporter that determine substrate specificity and selective uptake of purine analogues by either transporter is Purine antimetabolites have been in of a variety of diseases and of the many nucleobases and nucleosides with therapeutic and in and and and and and and protozoan Res. 1997; Google Scholar). The efficacy and selectivity of these drugs is at least in part dependent on the of transporters by the target Koning H.P. Int. J. Parasitol. 2001; 31: 512-522Crossref PubMed Scopus (99) Google Scholar, M. Pharmacol. 1998; Full Text Full Text PDF PubMed Scopus Google Scholar). studies have shown in the of purine transporters by and cells In Google Scholar, B. R. J. M. 1998; PubMed Scopus Google Scholar, R. M. M. 2000; PubMed Scopus (50) Google Scholar), the for an approach to that into transporter selectivity as as the of transporter The of uptake of antimetabolites such as S.M. P. J. Pharmacol. 1998; PubMed Scopus Google Scholar), W.B. Domin B.A. McConnell R.T. Zimmerman T.P. J. Biol. Chem. 1988; 263: 9285-9291Abstract Full Text PDF PubMed Google Scholar), (17Gati W.P. Paterson A.R. Tyrrell D.L. Cass C.E. Moravek J. Robins M.J. J. Biol. Chem. 1992; 267: 22272-22276Abstract Full Text PDF PubMed Google Scholar), or M. M. R. Biochem. Pharmacol. 1993; PubMed Scopus Google Scholar) has also been However, the of the transporter recognition motifs of the purine transporters allows as to the of uptake for a of purine we have previously shown for the T. b. brucei P1 and P2 transporters of the at may bind the permeant by to different of the purine these transporters very for adenosine m of and the different interactions in the to very different substrate selectivity (21De Koning H.P. Jarvis S.M. Mol. Pharmacol. 1999; 56: 1162-1170Crossref PubMed Scopus (129) Google Scholar). The substrate recognition models the of the P2 transporter in the uptake of the trypanocidal drugs (2Carter N.S. Fairlamb A.H. Nature. 1993; 361: 173-176Crossref PubMed Scopus (310) Google Scholar, Koning H.P. Jarvis S.M. Mol. Pharmacol. 1999; 56: 1162-1170Crossref PubMed Scopus (129) Google Scholar, M.P. Fairlamb A.H. Parasitol. 1999; Full Text Full Text PDF PubMed Scopus Google Scholar), P1 displayed to 100-fold affinity for these (21De Koning H.P. Jarvis S.M. Mol. Pharmacol. 1999; 56: 1162-1170Crossref PubMed Scopus (129) Google Scholar) and has not been in the uptake of The present study that that H2 and hFNT1 also interact very with the purine transporters are described as high affinity nucleobase but the H2 transporter displayed affinity for hFNT1 hypoxanthine with its substrate adenine. The of H2 to very high affinity to and appears to be to its potential to form with either the group or the N1 proton of the form of In contrast, by hFNT1 an N1 as present in hFNT1 high affinity for guanine to a hydrogen to the 6-keto group and a to the amine at these interactions to be in the H2 and transporter affinity for guanine than for for The by the two transporters is a by with N3, which is in all xanthine and This is with the of for xanthine compared with hypoxanthine by which of the of the N3 H-bond and the of the at For hFNT1 the affinity of xanthine also be to be than for because an H-bond such as an amine appears to be in but we were to a to of the hFNT1 transporter was not by to but H2 also to bind in which N7 is The lack of affinity of these transporters for which at to in human is an to the bloodstream because the high with low of other purine and be for the of Purine nucleobase transporters in a of other G. J. Biol. Chem. 1995; 270: Full Text Full Text PDF PubMed Scopus Google Scholar, G. PubMed Google Scholar), J. Google Scholar), do transport transporters of their from interactions with the part of the purine ring, explaining their of However, H2 forms with N7 and was directly in interactions with The that π-π stacking of the purine and or more in the transporter an in the of the permeant is not studies have shown that stacking a in the of many enzymes J. J. Mol. Biol. 1998; PubMed Scopus Google Scholar, B. Biol. 1996; PubMed Scopus (99) Google Scholar, 1996; PubMed Scopus Google Scholar, G. M. J. Mol. Biol. 1998; PubMed Scopus Google Scholar) and in the of Biophys. 2001; 30: PubMed Scopus Google Scholar). studies also showed that is in large part for the very high affinity of the T. b. brucei P2 transporter (21De Koning H.P. Jarvis S.M. Mol. Pharmacol. 1999; 56: 1162-1170Crossref PubMed Scopus (129) Google Scholar). The and interactions the of at J. J. Mol. Biol. 1991; PubMed Scopus Google Scholar). The models for the substrate recognition motif for H2 and hFNT1 show that is for selective uptake of purine analogues by either are the and higher for and by hFNT1 much higher affinity for and of selectivity be achieved with hypoxanthine because these the affinity the two m is However, the hFNT1 or of the transporter appears to be the most human nucleobase transporter and the only in other nucleobase transporters have been in cells of the and Koning H.P. Diallinas G. Mol. Membr. Biol. 2000; 75: 75-94Google Scholar). nucleobase transporters usually high affinity for their and to be expressed at the of the bloodstream with other The of of transporters for the side and of therapeutic nucleobase analogues for for their and is not that selective uptake alone be for selective therapeutic effects. as the accumulation of the is the to and the in a that the This is in the current study with the lack of in trypanocidal action of several and which displayed very high affinity for H2 and were most efficiently by the these are and other B.A. 1991; Google Scholar, 1993; 7: Google Scholar). the current study not to purine several of the used in the structural and trypanocidal action in However, these were not high affinity of H2 on the substrate recognition motifs (21De Koning H.P. Jarvis S.M. Mol. Pharmacol. 1999; 56: 1162-1170Crossref PubMed Scopus (129) Google Scholar), of the P2 In we have developed models for substrate recognition by the human and T. b. brucei nucleobase transporters and that these predict of the transporters for purine analogues with chemotherapeutic The very different mechanisms by which these transporters interact with their that the of their is to be The used in study a more approach to interactions than or and will be to such studies these possible the of the transporters
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Wallace et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: